A phase 1 dose-escalation study of low-dose lenalidomide maintenance post-allogeneic stem cell transplantation for high-risk acute myeloid leukaemia or myelodysplastic syndrome

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2024-07, Vol.59 (7), p.1025-1027
Hauptverfasser:	Koo, Ray Mun, Wong, Eric, Davis, Joanne E., Perera, Travis, Lim, Andrew, Koldej, Rachel M., Ritchie, David S.
Format:	Artikel
Sprache:	eng
Schlagworte:	13 13/31 631/250/1854/2812 631/250/1904 692/308/575 692/699/1541/1990/1673 692/699/1541/1990/283/1897 Acute myeloid leukemia Adult Aged Allografts Cell Biology Correspondence Female Hematology Hematopoietic Stem Cell Transplantation - methods Humans Internal Medicine Lenalidomide - administration & dosage Lenalidomide - therapeutic use Leukemia Leukemia, Myeloid, Acute - therapy Male Medicine Medicine & Public Health Middle Aged Myelodysplastic syndrome Myelodysplastic Syndromes - therapy Public Health Stem cell transplantation Stem Cells Transplantation, Homologous - methods
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!